97314 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Humanized anti-MUC1* antibodies
#902Compositions and Methods for Treating Cancer Expressing CD90 and CD326
#903ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
#904BCMA chimeric antigen receptors and uses thereof
#905A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL
#906ISOLATED CHIMERIC ANTIGEN RECEPTOR, MODIFIED T CELL COMPRISING SAME AND USE THEREOF
#907CHIMERIC ANTIGEN RECEPTORS WITH CD2 ACTIVATION
#908Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#909METHODS OF GENERATING CELLS
#910DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING
#911REPEAT DOSING OF HYPOIMMUNOGENIC CELLS
#912FULLY HUMAN ANTI-HUMAN CD22 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF
#913B7-H3 CHIMERIC ANTIGEN RECEPTORS
#914MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS
#915DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD
#916METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE
#917COMPOSITIONS AND METHODS OF ADAMTS13 CHIMERIC AUTOANTIBODY RECEPTOR CELLS
#918BCMA-SPECIFIC ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR
#919PSEUDOTYPED VIRUSES CONFIGURED TO EXPRESS CAR IN T-CELLS
#920GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD276
#921BCMA targetting antibodies, chimeric antigen receptors, and uses thereof
#922ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF
#923PLASMID ENCODING B-CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) AND USES OF SAME IN THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES IN FISH
#924Selectively controllable cleavable linkers
#925CHIMERIC POLYPEPTIDE FOR REGULATING IMMUNE CELLS
#926GPC3 CAR- T CELLS SECRETING IL-18 AND METHODS OF MAKING AND USING THE SAME
#927CD229 Car T Cells And Methods Of Use Thereof
#928Multivalent OspA polypeptides and methods and uses relating thereto
#929GENETICALLY MODIFIED IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR AND HAVING REDUCED PROINFLAMMATORY CYTOKINE SIGNALING
#930Polypeptides having xylanase activity and polynucleotides encoding same
#931CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF
#932GPC3 CAR- T CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#933Use of aprotinin as a carrier to produce a recombinant protein, polypeptide or peptide in algae
#934SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
#935ALL-IN ONE VECTOR FOR CAR AND THERAPEUTIC EFFECTOR MOLECULE
#936CD8 BINDING AGENTS
#937NON-HUMAN ANIMAL SECRETOME MODELS
#938Plant lectins as carriers of associated drug substances into animal and human cells
#939CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
#940RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF
#941GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#942CHIMERIC ANTIGEN RECEPTOR COMPRISING THIRD SIGNAL RECEPTOR AND USE THEREOF
#943Delivery of card protein as therapy for ocular inflammation
#944NPP1 FUSION PROTEINS
#945MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#946MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF
#947ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF
#948D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#949METASTASIS INHIBITING PROTEIN
#950Compositions and methods for targeting CD33-expressing cancers
#951Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell
#952METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES
#953CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGEN AND USE THEREOF
#954USE OF EGFR/HER2 TYROSINE KINASE INHIBITORS AND/OR HER2/HER3 ANTIBODIES FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS
#955NON-VIRAL TRANSCRIPTION ACTIVATION DOMAINS AND METHODS AND USES RELATED THERETO
#956OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM
#957QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING SPYCATCHER AND SPYTAG UNIVERSAL IMMUNE RECEPTORS
#958Composition and Methods for Selective Degradation of Engineered Proteins
#959FUSION PROTEINS AND USES THEREOF
#960CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES
#961ENGINEERED T CELLS AND METHODS OF PRODUCING THEREOF
#962RECOMBINANT BCG, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#963Non-human animals comprising a humanized TTR locus and methods of use
#964Methods to spatially profile protease activity in tissue and sections
#965PDE5 compositions and methods for immunotherapy
#966UNIVERSAL DONOR CELLS
#967EXPORTED RNA REPORTERS FOR LIVE-CELL MEASUREMENT
#968UNIVERSAL DONOR CELLS
#969New mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy
#970CHIMERIC ANTIGEN RECEPTORS FOR REMOVAL OF AMYLOID
#971CLATHRIN-CHIMETIC ANTIBODY RECEPTOR CONSTRUCTS FOR IMMUNE CELL ACTIVATION THERAPY IN VIVO
#972MODULATING GAMMA-C-CYTOKINE ACTIVITY
#973UNIVERSAL CAR-T TARGETING T-CELL LYMPHOMA CELL AND PREPARATION METHOD THEREFOR AND USE THEREOF
#974Chimeric molecules providing targeted costimulation for adoptive cell therapy
#975NOVEL DOMINANT NEGATIVE FAS POLYPEPTIDES, CELLS COMPRISING THEREOF AND USES THEREOF
#976METHODS AND COMPOSITIONS FOR TREATING DISEASE USING TARGETED FOXP3+CD4+ T CELLS AND CELLULAR SUICIDE AGENTS
#977RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
#978BCMA-Targeted Chimeric Antigen Receptor as well as Preparation Method Therefor and Application Thereof
#979COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY
#980CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#981CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF
#982METHODS FOR MANUFACTURING GENETICALLY ENGINEERED CAR-T CELLS
#983ENGINEERED T CELLS
#984Chimeric antigen receptors targeting CD70
#985SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS
#986BCMA-binding antibody and use thereof
#987EXPRESSION OF SEQUENCE-ENGINEERED LAMBDA ANTIBODY LIGHT CHAINS
#988CHIMERIC ANTIGEN RECEPTORS THAT BIND TO PROSTATE SPECIFIC MEMBRANE ANTIGEN
#989MULTISPECIFIC NANOBODIES CHIMERIC ANTIGEN RECEPTOR AND T-CELL ENGAGER, NUCLEIC ACID, EXPRESSING CELL THEREOF, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELL
#990THERAPEUTIC ADENO-ASSOCIATED VIRUS COMPRISING LIVER-SPECIFIC PROMOTERS FOR TREATING POMPE DISEASE AND LYSOSOMAL DISORDERS
#991CHIMERIC CHLOROTOXIN RECEPTORS
#992ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF
#993BCG CAR CONSTRUCTS AND METHODS OF THEIR MANUFACTURE AND USE
#994Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
#995NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF
#996METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING A SAGE1-RELATED CONDITION
#997DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#998BCMA-DIRECTED CELLULAR IMMUNOTHERAPY COMPOSITIONS AND METHODS
#999Rapid assay for detection of SARS-CoV-2 antibodies
#1000SPLIT DEAMINASE BASE EDITORS
#1001MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY
#1002Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof
#1003METASTATIC BRAIN TUMOR TARGETING PEPTIDES
#1004CRM197 protein expression
#1005CHIMERIC ANTIGEN RECEPTOR TO WHICH ANTI-COTININE ANTIBODY IS LINKED, AND USE THEREOF
#1006MARROW INFILTRATING LYMPHOCYTES (MILS) AS A SOURCE OF T-CELLS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) THEREAPY
#1007ENGINEERED CELLS WITH IMPROVED PROTECTION FROM NATURAL KILLER CELL KILLING
#1008CHIMERIC ANTIGEN RECEPTOR
#1009Receptors providing targeted costimulation for adoptive cell therapy
#1010TRUNCATED NKG2D CHIMERIC RECEPTORS AND USES THEREOF IN NATURAL KILLER CELL IMMUNOTHERAPY
#1011N-TERMINAL EXTENSION SEQUENCE FOR EXPRESSION OF RECOMBINANT THERAPEUTIC PEPTIDES
#1012IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF THE IL-1 SUPERFAMILY
#1013CHIMERIC TRANSCRIPTION FACTOR VARIANTS WITH AUGMENTED SENSITIVITY TO DRUG LIGAND INDUCTION OF TRANSGENE EXPRESSION IN MAMMALIAN CELLS
#1014CODON OPTIMIZED NEW GENERATION REGULATABLE FUSOGENIC ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 VIRUS AND METHODS OF USE
#1015RECOMBINANT NEURAMINIDASE AND USES THEREOF
#1016PEPTIDE-HINGE-FREE FLEXIBLE ANTIBODY-LIKE MOLECULE
#1017PROTEASE SWITCH FOR DUAL TARGETS CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
#1018NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN
#1019Activatable cytokine constructs and related compositions and methods
#1020CHIMERIC FILOVIRUS VACCINES
#1021TARGETING PD-L1 ON TUMOR CELLS
#1022SYNTHETIC ALPHA-SECRETASE AND USE THEREOF
#1023ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE
#1024ENGINEERED T CELL RECEPTORS AND USES THEREOF
#1025COMPOSITIONS AND METHODS REGULATING FOLLICULOGENESIS FOR THE TREATMENT OF OVARIAN SENESCENCE
#1026DNase I variants, compositions, methods, and kits
#1027IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#1028TRANSGENE GENETIC TAGS AND METHODS OF USE
#1029TMEM59 PROTEIN DIMER OR CHIMERIC EXPRESSION RECEPTOR IMPROVING T CELL FUNCTION
#1030FUSION PROTEIN COMPRISING HUMAN LEFTY A PROTEIN VARIANTS AND USE THEREOF
#1031METHODS OF INDUCING NEOEPITOPE-SPECIFIC T CELLS WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE
#1032DIMERIZATION SWITCHES AND USES THEREOF
#1033BIOSYNTHESIS OF MOGROSIDES
#1034CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
#1035DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS
#1036Multispecific binders of TGFBeta-superfamily ligands and uses thereof
#1037ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE
#1038Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#1039HUMAN ANTI-ANTXR CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#1040METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#1041Combination therapies for treating cancer
#1042CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF
#1043Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof
#1044METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
#1045COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
#1046Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders
#1047NON-HUMAN ANIMALS COMPRISING A HUMANIZED TRKB LOCUS
#1048ANTI-GLYPICAN-1-IMMUNIZING ANTIGEN RECEPTOR
#1049CLEC9A BINDING AGENTS
#1050ROR1 specific chimeric antigen receptors and their therapeutic applications
#1051TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF
#1052CHIMERIC COSTIMULATORY RECEPTORS AND METHODS AND USES THEREOF
#1053ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME
#1054Enhanced immune cells using dual shRNA and composition including the same
#1055Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
#1056ANTIGEN SPECIFIC CD19-TARGETED CAR-T CELLS
#1057COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF
#1058GALECTIN-TARGETING IMMUNOTHERAPY
#1059Genetically engineered cells
#1060POLYPEPTIDES COMPRISING AT LEAST TWO CARBOHYDRATE BINDING DOMAINS
#1061Chimeric antigen receptors targeting B-cell maturation antigen
#1062CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF
#1063CD8-specific antibody constructs and compositions thereof
#1064Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem Cells
#1065RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-MEDIATED KIDNEY DISORDERS
#1066FIBROBLAST ACTIVATION PROTEIN BINDING AGENTS AND USE THEREOF
#1067Methods of Activating and Proliferating Exhausted CD8 T Cells, CD8 T Cells with Enhanced Activity Prepared by the Same, and Uses Thereof
#1068CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF
#1069Combined Artificial Cell Death/Reporter System Polypeptide for Chimeric Antigen Receptor Cell and Uses Thereof
#1070CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION
#1071ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR SWITCHES AND USES THEREOF
#1072Methods and compositions for modulating CAR-T activity
#1073THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#1074CD25 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#1075Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy
#1076ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI
#1077CD33 TARGETED IMMUNOTHERAPIES
#1078Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#1079Compositions and Uses for Engineered Therapeutic Microbes and Associated Receptors
#1080CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#1081ANTI-HER2 AFFIBODY AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE
#1082CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2
#1083Compositions and methods for producing high secreted yields of recombinant proteins
#1084PLATFORM FOR ENHANCED TARGETED CELL DELIVERY
#1085NEF-CONTAINING T CELLS AND METHODS OF PRODUCING THEREOF
#1086Codon-optimized nucleotide sequences encoding an AP-1 transcription factor
#1087FUSION PROTEINS FOR IMPROVED ENZYME EXPRESSION
#1088IL1RAP ANTIBODIES
#1089CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
#1090Compositions and methods for producing high secreted yields of recombinant proteins
#1091METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES TO EXPRESS POLYPEPTIDES COMPRISING THE INTRACELLULAR DOMAIN OF CD79A AND CD79B
#1092GENETICALLY MODIFIED CELLS AND USES THEREOF
#1093CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD 300C ANTIGEN OR RECEPTOR THEREOF
#1094Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1
#1095AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY
#1096METHOD OF IDENTIFYING INTRACELLULAR SECRETORY PROTEIN OR TISSUE-SPECIFIC SECRETORY PROTEIN
#1097Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike protein
#1098ENGINEERED T CELLS AND USES THEREFOR
#1099mRNA CONSTRUCT FOR PROTEIN EXPRESSION AND USE OF SAME
#1100CAR library and scFv manufacturing method
#1101CHIMERIC CYTOKINE RECEPTOR CAPABLE OF IMMUNE SIGNAL CONVERSION, IMMUNE CELLS EXPRESSING SAME, AND ANTI-CANCER USE THEREOF
#1102ENGINEERED T CELLS AND METHODS OF PRODUCING THEREOF
#1103HV1 modulators and uses
#1104METHODS FOR IMPROVED EXTRACTION OF SPIDER SILK PROTEINS
#1105COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION
#1106GENETICALLY ENGINEERED T CELLS WITH PTPN2 KNOCKOUT HAVE IMPROVED FUNCTIONALITY AND ANTI-TUMOR ACTIVITY
#1107Endotoxin-free Production of Recombinant Subunit Vaccine Components
#1108Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
#1109MODIFIED HUMAN VARIABLE DOMAINS
#1110Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#1111Compositions and Methods for Treating Cancer with DuoCARs
#1112Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#1113SPYCATCHER AND SPYTAG: UNIVERSAL IMMUNE RECEPTORS FOR T CELLS
#1114CRM197 PROTEIN EXPRESSION METHOD
#1115DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME
#1116Engineered bacteria secreting therapeutic proteins and methods of use thereof
#1117SOLUBLE EXPRESSION OF PROTEIN USING PEPTIDE TAG
#1118RELAXIN ANALOGS AND METHODS OF USING THE SAME
#1119GENETICALLY MODIFIED NK CELLS AND USES THEREOF
#1120YEAST EXPRESSING THERMOSTABLE ALPHA-AMYLASES FOR HYDROLYSIS OF STARCH
#1121EPCAM BINDING PROTEINS AND METHODS OF USE
#1122FOXP3 TARGETING AGENT COMPOSITIONS AND METHODS OF USE FOR ADOPTIVE CELL THERAPY
#1123COMPOSITION AND METHOD FOR ADOPTIVE IMMUNOTHERAPY
#1124CELL
#1125NOVEL FUSION PROTEIN AND USE OF SAME
#1126CIRCULAR RNAS FOR CELLULAR THERAPY
#1127RECOMBINANT VACCINES AND USE THEREOF
#1128Method of co-expressing a sulfatase and a sulfatase modifying factor in a plant or plant cell
#1129Antibodies having specificity for CD38 and uses thereof
#1130INTERMEDIATE FILAMENT-DERIVED PEPTIDES AND THEIR USES
#1131Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
#1132Anti-abeta antibodies
#1133COMPOSITIONS AND METHODS OF ACETYLCHOLINE RECEPTOR CHIMERIC AUTOANTIBODY RECEPTOR CELLS
#1134Protease-resistant systems for polypeptide display and methods of making and using thereof
#1135METHOD
#1136HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF
#1137CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS
#1138CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY
#1139UNSPECIFIC PEROXYGENASE ENZYME VARIANTS FOR SELECTIVE FATTY ACID EPOXIDATION OR HYDROXYLATION
#1140Methods and compositions for modulating CAR-T activity
#1141CD79B CHIMERIC ANTIGEN RECEPTORS
#1142Humanized BCMA antibody and BCMA-CAR-T cells
#1143CHIMERIC RECEPTOR THERAPY
#1144CHIMERIC CO-STIMULATORY PROTEINS COMPRISING MUTANT INTRACELLULAR DOMAINS WITH INCREASED EXPRESSION
#1145Separation moieties and methods of use thereof
#1146AAV CAPSID CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#1147Universal donor cells
#1148CAR T-CELLS TARGETING BCMA AND USES THEREOF
#1149Rapid assay for detection of SARS-CoV-2 antibodies
#1150Expression Process
#1151ANTIGEN RECOGNIZING RECEPTORS TARGETING CD371 AND USES THEREOF
#1152MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES
#1153PROTEIN MOLECULE AND USE THEREOF
#1154GENOMIC SAFE HARBORS FOR TRANSGENE INTEGRATION
#1155Universal donor cells
#1156MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#1157CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19
#1158Humanized antibody specific for CD22 and chimeric antigen receptor using the same
#1159Rocky mountain spotted fever detection and treatment
#1160ENPP1 POLYPEPTIDES AND METHODS OF USING SAME
#1161Salvage chimeric antigen receptor systems
#1162COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#1163CO-USE OF LENALIDOMIDE WITH CAR-T CELLS
#1164Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof
#1165Genetically engineered dual-targeting chimeric antigen receptor and use thereof
#1166METHODS AND COMPOSITIONS FOR TREATING CANCER
#1167FMS-LIKE TYROSINE KINASE 3 LIGAND (FLT3L)-BASED CHIMERIC PROTEINS
#1168CELLS EXPRESSING A RECOMBINANT RECEPTOR FROM A MODIFIED TGFBR2 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS
#1169CD8 BINDING AGENTS
#1170TWO CHIMERIC ANTIGEN RECEPTORS SPECIFICALLY BINDING CD19 AND IGKAPPA
#1171Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma
#1172Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
#1173COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS
#1174Destabilising domains for conditionally stabilising a protein
#1175ENGINEERED ANTIBODIES
#1176Compositions and Methods for Treating Cancer with DuoCARs
#1177RECOMBINANT MILK PROTEINS AND FOOD COMPOSITIONS COMPRISING THE SAME
#1178T CELL RECEPTORS AND METHODS OF USE THEREOF
#1179HUMANIZED ANTI-FOLATE RECEPTOR 1 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#1180INTERLEUKIN 12 FUSION PROTEINS, AND COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
#1181RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
#1182IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#1183MUC16 specific chimeric antigen receptors and uses thereof
#1184MUC16 specific chimeric antigen receptors and uses thereof
#1185CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19
#1186LAMP constructs
#1187COMPOSITION FOR USE IN TREATMENT OF ALLERGIC DISEASES
#1188Optimized lentiviral transfer vectors and uses thereof
#1189INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS
#1190GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#1191CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#1192METHODS AND COMPOSITIONS FOR IL10 SIGNALING ANTAGONISM
#1193CHIMERIC TIM-3 FUSION PROTEIN
#1194GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#1195CHIMERIC ANTIGEN RECEPTOR (CAR) NK CELLS AND USES THEREOF
#1196A GENETICALLY MODIFIED LACTOBACILLUS AND USES THEREOF
#1197TCR FUSION PROTEIN AND CELL EXPRESSING TCR FUSION PROTEIN
#1198CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF
#1199Human monoclonal antibodies specific for FLT3 and uses thereof
#1200Antigen binding regions against fibronectin type III domains and methods of using the same